Human-based tissue scaffolds, including a biological vascular graft to provide vascular access to end-stage renal disease patients who need hemodialys....
There’s no risk. Start your trial today to see profiles of Humacyte (NASDAQ:HUMA) plus 5517 other startups.
Start Free 7 Day Trial Now
